The results also suggest that IL-17 in mice might activate splenocytes and/or medulloblastoma cells to produce chemokines Ccl20 and Ccl2, which might promote splenocyte recruitment and anti-tumor activity. The gene discussed is CCL2; the disease is medulloblastoma.